Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04972981
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Age Groups: adult | senior
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Sarah Cannon at HealthONE Denver Colorado 80218 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Emory University, Winship Cancer Institute Atlanta Georgia 30322 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University Hospitals of Cleveland Medical Center (UHCMC) Cleveland Ohio 44106 United States Details
Sarah Cannon at University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Institut Catala D'oncologia (ICO) - Hospital Duran I Reynals Location Badalona Barcelona 08908 Spain Details
Hospital Universitari Vall D'hebron - Vall D'hebron Institut D'oncologia (VHIO) Barcelona 08035 Spain Details
(START) Madrid - Hospital Universitario Fundación Jiménez Díaz Location Madrid 28040 Spain Details
Universidad Complutense de Madrid - Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Imperial College Healthcare NHS Trust - St Mary's Hospital London England W12 0HS United Kingdom Details
Sarah Cannon Research Institute (SCRI) - London (SCRI-UK) London England W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from for the field